| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |